GB9214720D0 - Enzyme inhibitors - Google Patents

Enzyme inhibitors

Info

Publication number
GB9214720D0
GB9214720D0 GB929214720A GB9214720A GB9214720D0 GB 9214720 D0 GB9214720 D0 GB 9214720D0 GB 929214720 A GB929214720 A GB 929214720A GB 9214720 A GB9214720 A GB 9214720A GB 9214720 D0 GB9214720 D0 GB 9214720D0
Authority
GB
United Kingdom
Prior art keywords
enzyme inhibitors
inhibitors
enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929214720A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to GB929214720A priority Critical patent/GB9214720D0/en
Publication of GB9214720D0 publication Critical patent/GB9214720D0/en
Priority to JP6503128A priority patent/JPH07508983A/en
Priority to CA002139836A priority patent/CA2139836A1/en
Priority to ZA934970A priority patent/ZA934970B/en
Priority to EP93914912A priority patent/EP0649413A1/en
Priority to IL106290A priority patent/IL106290A0/en
Priority to MX9304152A priority patent/MX9304152A/en
Priority to PCT/GB1993/001443 priority patent/WO1994001414A1/en
Priority to AU45116/93A priority patent/AU4511693A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
GB929214720A 1992-07-10 1992-07-10 Enzyme inhibitors Pending GB9214720D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB929214720A GB9214720D0 (en) 1992-07-10 1992-07-10 Enzyme inhibitors
JP6503128A JPH07508983A (en) 1992-07-10 1993-07-09 Uracil derivatives as enzyme inhibitors
CA002139836A CA2139836A1 (en) 1992-07-10 1993-07-09 Iracil derivatives as enzyme inhibitors
ZA934970A ZA934970B (en) 1992-07-10 1993-07-09 Enzyme inhibitors
EP93914912A EP0649413A1 (en) 1992-07-10 1993-07-09 Uracil derivatives as enzyme inhibitors
IL106290A IL106290A0 (en) 1992-07-10 1993-07-09 Enzyme inhibitors,their preparation and pharmaceutical compositions containing them
MX9304152A MX9304152A (en) 1992-07-10 1993-07-09 ENZYME INHIBITORS.
PCT/GB1993/001443 WO1994001414A1 (en) 1992-07-10 1993-07-09 Uracil derivatives as enzyme inhibitors
AU45116/93A AU4511693A (en) 1992-07-10 1993-07-09 Uracil derivatives as enzyme inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929214720A GB9214720D0 (en) 1992-07-10 1992-07-10 Enzyme inhibitors

Publications (1)

Publication Number Publication Date
GB9214720D0 true GB9214720D0 (en) 1992-08-19

Family

ID=10718537

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929214720A Pending GB9214720D0 (en) 1992-07-10 1992-07-10 Enzyme inhibitors

Country Status (9)

Country Link
EP (1) EP0649413A1 (en)
JP (1) JPH07508983A (en)
AU (1) AU4511693A (en)
CA (1) CA2139836A1 (en)
GB (1) GB9214720D0 (en)
IL (1) IL106290A0 (en)
MX (1) MX9304152A (en)
WO (1) WO1994001414A1 (en)
ZA (1) ZA934970B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1306123B1 (en) 1999-04-02 2001-05-30 Technopharma Sa VISCOSIZED OPHTHALMIC SOLUTION WITH CLEANSING ACTION ON THE CONTACT LENSES.
AR039540A1 (en) * 2002-05-13 2005-02-23 Tibotec Pharm Ltd MICROBICIDE COMPOUNDS WITH PIRIMIDINE OR TRIAZINE CONTENT
EP1652832A4 (en) * 2003-08-06 2007-05-16 Sumitomo Chemical Co Hydroxy-protecting reagent and method of protecting hydroxy with the same
WO2007024863A2 (en) 2005-08-22 2007-03-01 Melior Discovery, Inc. Methods and formulations for modulating lyn kinase activity and treating related disorders
US8552184B2 (en) * 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
RU2427373C1 (en) 2010-11-08 2011-08-27 Виктор Вениаминович Тец Method for endogenous interferon induction
CN110785170B (en) 2017-04-10 2023-03-28 梅里奥尔医药I公司 Treatment of adipocytes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613604A (en) * 1985-07-31 1986-09-23 Brown University Research Foundation Hydroxymethyl derivatives of 5-benzylacyclouridine and 5-benzoyloxybenzylacyclouridine and their use as potentiators for 5-fluoro-2'-deoxyuridine
JPS63290867A (en) * 1987-05-22 1988-11-28 Sds Biotech Kk Uracil compound and fungicide
US5077280A (en) * 1988-04-12 1991-12-31 Brown University Research Foundation Treatment of viral infections
DE69126469T2 (en) * 1990-03-29 1998-01-29 Mitsubishi Chem Corp Pyrimidine nucleoside derivatives and antiviral agents containing these derivatives as an active ingredient
US5141943A (en) * 1990-04-12 1992-08-25 Brown University Research Foundation 5-benzyl barbiturate derivatives

Also Published As

Publication number Publication date
EP0649413A1 (en) 1995-04-26
CA2139836A1 (en) 1994-01-20
JPH07508983A (en) 1995-10-05
ZA934970B (en) 1995-01-09
MX9304152A (en) 1994-04-29
IL106290A0 (en) 1993-11-15
AU4511693A (en) 1994-01-31
WO1994001414A1 (en) 1994-01-20

Similar Documents

Publication Publication Date Title
IL108075A0 (en) Enzyme inhibitors
ZA917096B (en) Enzyme inhibitors
AU5533094A (en) Enzyme inhibitors
HU9302080D0 (en) Amine-diole protease inhibitors
EP0835109A4 (en) Pyridinone-thrombin inhibitors
PL321759A1 (en) Novel thrombosin inhibitors
HU9601508D0 (en) Dp-iv-serine protease inhibitors
HU9303093D0 (en) Enzyme systhems
IL123653A0 (en) Chemokine inhibitor
GB9315846D0 (en) Tumour inhibitors
GB9425701D0 (en) Enzyme inhibitors
HU9503783D0 (en) Squvalen syntetase inhibitors
GB9502985D0 (en) Enzyme inhibitors
ZA934970B (en) Enzyme inhibitors
ZA939480B (en) Enzyme inhibitor
GB9212261D0 (en) Enzyme cloning
GB9303051D0 (en) 17b-nmonosubstituted carbamoyl-11-oxo-4-aza-5-a-androst-en-3-one testosterone-5-alpha reductase inhibitors
ZA949525B (en) Enzyme inhibitors
ZA938867B (en) Enzyme inhibitors
GB9007750D0 (en) Enzyme inhibitors
GB9319663D0 (en) Enzyme inhibitors
GB9324981D0 (en) Enzyme inhibitors
ZA924089B (en) Novel thrombin inhibitors
KR100195376B1 (en) Haloethyl-substituted steroid enzyme inhibitors
GB9500553D0 (en) Enzyme inhibitors